ConductScience.org, home

Trial · NCT01238536

Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial)

NCT01238536, Phase 4, Completed, University of Washington; results first posted 2017-12-13

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial). Trials, record NCT01238536. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01238536

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial)
NCT number
NCT01238536
Status
Completed
Phases
Phase 4
Enrollment
400 participants, actual
Lead sponsor
University of Washington
Conditions
Spinal Stenosis, Low Back Pain
Interventions
Epidural steroid with local anesthetic injection, Epidural local anesthetic injection, Epidural steroid injection, Epidural local anesthetic injection
First posted
2010-11-10
Last updated
2017-12-13
Results first posted
2017-12-13

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryRoland Morris6 weeks
The primary outcome measure will be back specific functional status, measured by the Roland Scale at 6 weeks. The RDQ is a back pain specific functional status questionnaire adapted from the Sickness Impact Profile (SIP). The RDQ consists of 24 yes/no items, which represent common dysfunctions in daily activities experienced by subjects with low back pain. A single unweighted score is derived by summing the 24 items, with higher scores indicating worse function with 0 (no disability) to 24 (maximum disability). Our primary analysis will be a simple 2-group comparison of the mean Roland score as an evaluation of the short-term efficacy of epidural steroid injection.
SecondaryPain Numeric Rating Scale6 weeksLeg Pain NRS is a second primary outcome at 6 weeks We measured leg pain using a 0-10 pain NRS (0=no pain and 10=worst pain imaginable) assessing average pain over the past week.
SecondaryRoland Morris Disability Questionnaire (RDQ)12 months
The RDQ is a back pain specific functional status questionnaire adapted from the Sickness Impact Profile (SIP). The RDQ consists of 24 yes/no items, which represent common dysfunctions in daily activities experienced by subjects with low back pain. A single unweighted score is derived by summing the 24 items, with higher scores indicating worse function with 0 (no disability) to 24 (maximum disability). Our primary analysis will be a simple 2-group comparison of the mean Roland score as an evaluation of the short-term efficacy of epidural steroid injection.
SecondaryLeg Pain NRS12 monthsLeg Pain NRS 0-10 scale

Outcomes4

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYRoland Morris6 weeks6 week follow up rate was 97% (n=193/200, n=193/200).units on a scaleMEAN
SECONDARYPain Numeric Rating Scale6 weeksunits on a scaleMEAN
SECONDARYRoland Morris Disability Questionnaire (RDQ)12 monthsunits on a scaleMEAN
SECONDARYLeg Pain NRS12 monthsunits on a scaleMEAN

Results by group8

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Roland MorrisEpidural Steroid Injection11.8Standard Deviation 6.3units on a scale
Roland MorrisEpidural Local Anesthetic Injection12.5Standard Deviation 6.4units on a scale
Pain Numeric Rating ScaleEpidural Steroid Injection4.4Standard Deviation 2.9units on a scale
Pain Numeric Rating ScaleEpidural Local Anesthetic Injection4.6Standard Deviation 2.9units on a scale
Roland Morris Disability Questionnaire (RDQ)Epidural Steroid Injection12.0Standard Deviation 6.5units on a scale
Roland Morris Disability Questionnaire (RDQ)Epidural Local Anesthetic Injection11.5Standard Deviation 7.1units on a scale
Leg Pain NRSEpidural Steroid Injection4.7Standard Deviation 3.1units on a scale
Leg Pain NRSEpidural Local Anesthetic Injection4.3Standard Deviation 3.1units on a scale

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDEpidural Steroid Injection200
Overall StudySTARTEDEpidural Local Anesthetic Injection200
Overall StudyCOMPLETEDEpidural Steroid Injection153
Overall StudyCOMPLETEDEpidural Local Anesthetic Injection150
Overall StudyNOT COMPLETEDEpidural Steroid Injection47
Overall StudyNOT COMPLETEDEpidural Local Anesthetic Injection50

Adverse events6

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherDural punctureInjury, poisoning and procedural complicationsEpidural Steroid Injection12001
otherDural punctureInjury, poisoning and procedural complicationsEpidural Local Anesthetic Injection12001
otherAll other self reported adverse eventsGeneral disordersEpidural Steroid Injection4320057
otherAll other self reported adverse eventsGeneral disordersEpidural Local Anesthetic Injection3120033
seriousHospitalization or SurgerySurgical and medical proceduresEpidural Steroid Injection52005
seriousHospitalization or SurgerySurgical and medical proceduresEpidural Local Anesthetic Injection42004

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityEpidural Steroid Injection
Total, all-cause mortalityEpidural Local Anesthetic Injection
Total, other adverse eventsEpidural Steroid Injection43200
Total, other adverse eventsEpidural Local Anesthetic Injection31200
Total, serious adverse eventsEpidural Steroid Injection5200
Total, serious adverse eventsEpidural Local Anesthetic Injection4200

Papers5

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
22458343BACKGROUNDPubMed
24988555RESULTPubMed
26010037RESULTPubMed
26096484RESULTPubMed
28396242DERIVEDPubMed

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R01HS019222Back pain Outcomes using Longitudinal Data (BOLD)JARVIK, JEFFREY GUNIVERSITY OF WASHINGTONAGENCY FOR HEALTHCARE RESEARCH AND QUALITY2010

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Epidural Steroid Injection vs Epidural Local Anesthetic Injection: serious adverse events

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01238536

GET https://conductscience.org/api/trials/v1/NCT01238536/registered